awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34593276-4DF31067-AAF5-436B-8AD5-DDA6A43D8C20
Q34593276-4DF31067-AAF5-436B-8AD5-DDA6A43D8C20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-4DF31067-AAF5-436B-8AD5-DDA6A43D8C20
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study
P2860
Q34593276-4DF31067-AAF5-436B-8AD5-DDA6A43D8C20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34593276-4DF31067-AAF5-436B-8AD5-DDA6A43D8C20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11d09fc2cfcc1b5f5f869354b580656831b4c52f
P2860
Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints.